CDMO Expansions: • SEQENS has entered into exclusive negotiations with Novartis for the potential acquisition of the French company Cellforcure and its cell & gene therapy development and production site. CELLforCURE’s has large-scale industrial production of cell & gene therapies. With over 10,000
top of page
To see this working, head to your live site.
Welcome! Have a look around and join the conversations.
AT Biomanufacturing Updates
The Berke Report
bottom of page